Immune checkpoint inhibitor target found to promote skin cancer growth

Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various types of cancer.

Genentech’s food allergy medication gets priority review nod from the FDA

Genentech’s Xolair scored a priority review from the FDA on Wednesday for the reduction of allergic reactions in adult and pediatric patients 1 year and

December 21, 2023

Bruker’s New NeuraLeap Delivers Unprecedented Imaging Speed Across Optical Planes

Novel Use of Digital Micromirror Device Enables Variable Depth-of-Field Collection for Advanced Neuroscience Research

September 6, 2023

STAT wants to know your pick for a great summer read or listen

STAT is putting together a list of books and podcasts that deal with health, medicine, and the life sciences that would be great to check

June 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.